4 withdrawn. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Withdrawn 4 |
| Phase 2 | 3 | Withdrawn 3 |
Follow Hypoglycemia: new trials by email Literature Review of Hypoglycemia trials Research Report on Hypoglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia Allogeneic Pancreatic Endocrine Cell Clusters - Diabetes Mellitus Type 1 | Phase 1 / Phase 2 | Withdrawn | Seraxis | 2025-04-01 | 2025-10-16 | |
| Diabetes Islet Preservation Immune Treatment Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1 / Phase 2 | Withdrawn | Camillo Ricordi and Jay Skyler | 2024-06-01 | 2026-01-15 | |
| Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1D AT-1501 IV Infusion, Isolated cadaveric islet cells - Brittle Type 1 Diabetes Mellitus | Phase 1 / Phase 2 | Withdrawn | Eledon Pharmaceuticals | 2022-09-30 | 2023-01-18 | |
| Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression Islet cell transplantation - Islet Cell Transplantation, Type 1 Diabetes | Phase 1 | Withdrawn | Baylor Research Institute | 2008-07-01 | 2017-02-15 |
Diabetes Mellitus (4) · Diabetes Mellitus, Type 1 (4) · Autoimmune Diseases (2) · Endocrine System Diseases (2) · Hyperglycemia (2) · Glucose Metabolism Disorders (1) · Immune System Diseases (1) · Metabolic Diseases (1)
Nutritional and Metabolic Diseases (4) · Glucose Metabolism Disorders (3) · Immune System Diseases (3) · Metabolic Diseases (3) · Autoimmune Diseases (2) · Endocrine System Diseases (2)
Adalimumab (1) · Antilymphocyte Serum (1) · Exenatide (1) · Interleukin-2 (1) · Islets of Langerhans Transplantation (1) · aldesleukin (1) · thymoglobulin (1)
Baylor Research Institute (1) · Camillo Ricordi and Jay Skyler (1) · Eledon Pharmaceuticals (1) · Seraxis (1)
United States (3)
Jeff Bornstein, MD (1) · Rodolfo Alejandro, M.D. (1)